Patently Unconstitutional? Lawsuit Proceeds Over BRCA Gene Patents
Researchers challenging the patents on the BRCA1 and BRCA2 breast cancer genes won the first round in their suit against the U.S. Patent and Trademark Office and molecular diagnostics firm Myriad Genetics when a court denied the defendants' request to dismiss the case
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
